These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6210671)

  • 1. Comparison of the efficacy and safety of mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.
    González MA
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():229-30. PubMed ID: 6210671
    [No Abstract]   [Full Text] [Related]  

  • 2. Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.
    Leal del Rosal P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():227-8. PubMed ID: 6210670
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: a prospective randomized trail.
    Ramírez-Ronda CH; Gutiérrez J; Bermúdez RH
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():125-9. PubMed ID: 6210660
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized double blinded comparison of mezlocillin and ticarcillin for the treatment of respiratory infections.
    McCloskey RV; Killebrew D; Tutlane V; Bentley J
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():209-13. PubMed ID: 6210668
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of mezlocillin and ticarcillin in the treatment of urinary tract infections.
    Madsen PO; Nielsen OS
    Clin Ther; 1980; 3(4):311-5. PubMed ID: 6456068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of complicated urinary tract infection with mezlocillin and ticarcillin, a comparative study.
    Madsen PO; Nielsen OS
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():179-81. PubMed ID: 6210665
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mezlocillin in the treatment of septicemia and bronchopneumonia caused by Gram-negative bacilli].
    Klastersky J; Sculier JM; Hanson B; Coppens L
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):383-5. PubMed ID: 6460981
    [No Abstract]   [Full Text] [Related]  

  • 8. Mezlocillin in neonatal infections: evaluation of efficacy and toxicity.
    Chiu T; Garrison RD; Fakhreddine F; Ayoub EM
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():251-5. PubMed ID: 6210675
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with mezlocillin in Europe-overview.
    Konopka CA; Arcieri G; Schacht P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():267-72. PubMed ID: 6210678
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative clinical evaluation of mezlocillin and cefoxitin.
    LeFrock JL; Molavi A; Carr B; Schell R; Smith B; Rolston K; Lentnek A
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():199-203. PubMed ID: 6210667
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of mezlocillin in discriminative animal models of infection.
    Scheld WM; Brodeur JP; Keeley JM
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():51-64. PubMed ID: 6210683
    [No Abstract]   [Full Text] [Related]  

  • 12. Mezlocillin in infants and children: efficacy, safety and pharmacokinetics.
    Trujillo H; Bustos-González A; Peláez LC; Halpert D; Mejía G; Zapata CT; Taboada B
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():263-5. PubMed ID: 6210677
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety and tolerance of mezlocillin.
    Parry MF; Neu HC
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():273-80. PubMed ID: 6210679
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of mezlocillin in female genital tract infections.
    Marshall JR; Chow AW; Sorrell TC
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():149-58. PubMed ID: 6210661
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic therapy for anaerobic infections.
    Weber SJ; Lefrock JL
    Am Fam Physician; 1985 Apr; 31(4):212-6. PubMed ID: 3984824
    [No Abstract]   [Full Text] [Related]  

  • 16. Timentin in the treatment of nosocomial bronchopulmonary infections in intensive care units.
    Schwigon CD; Hulla FW; Schulze B; Maslak A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():115-22. PubMed ID: 3636326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mezlocillin in aerobic and anaerobic infections.
    Thadepalli H; Rao B; Dhawan VK; Bach VT
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():115-9. PubMed ID: 6210658
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and pharmacokinetics of Timentin in paediatric infections.
    Bégué P; Quiniou F; Quinet B
    J Antimicrob Chemother; 1986 May; 17 Suppl C():81-91. PubMed ID: 3636339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
    Levison ME; Kobasa WD
    Antimicrob Agents Chemother; 1984 Jun; 25(6):683-6. PubMed ID: 6742813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.